BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
Bio-Techne (NASDAQ: TECH) will showcase its portfolio at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting from November 6-10, 2024, in Houston, Texas. The company's spatial biology brands, Advanced Cell Diagnostics (ACD) and Lunaphore, will present their innovations at booths #613 and #701 respectively.
ACD will showcase spatial multiomics products featuring RNAscope™ technology, while Lunaphore will demonstrate its automated COMET™ suite and HORIZON™ image analysis software. The company will present multiple posters highlighting research applications, including multiomic mapping of the brain, immune cell profiling, and biomarker detection studies. Collaborative research presentations with prominent institutions will also be featured.
Bio-Techne (NASDAQ: TECH) presenterà il suo portfolio al 39° Incontro Annuale della Società per l'Immunoterapia del Cancro (SITC), che si svolgerà dal 6 al 10 novembre 2024, a Houston, Texas. I marchi di biologia spaziale dell'azienda, Advanced Cell Diagnostics (ACD) e Lunaphore, presenteranno le loro innovazioni agli stand #613 e #701 rispettivamente.
ACD mostrerà prodotti di multiomica spaziale con tecnologia RNAscope™, mentre Lunaphore dimostrerà il suo suite automatizzata COMET™ e il software di analisi delle immagini HORIZON™. L'azienda presenterà numerosi poster che evidenziano le applicazioni di ricerca, inclusa la mappatura multiomica del cervello, il profilaggio delle cellule immunitarie e gli studi sulla rilevazione di biomarcatori. Saranno anche presentate presentazioni di ricerca collaborative con istituzioni di spicco.
Bio-Techne (NASDAQ: TECH) presentará su cartera en la 39ª Reunión Anual de la Asociación para la Inmunoterapia del Cáncer (SITC), que se llevará a cabo del 6 al 10 de noviembre de 2024 en Houston, Texas. Las marcas de biología espacial de la compañía, Advanced Cell Diagnostics (ACD) y Lunaphore, presentarán sus innovaciones en los stands #613 y #701 respectivamente.
ACD exhibirá productos de multiómica espacial que cuentan con la tecnología RNAscope™, mientras que Lunaphore demostrará su suite automatizada COMET™ y el software de análisis de imágenes HORIZON™. La empresa presentará varios pósteres destacando aplicaciones de investigación, incluyendo la mapeo multiómico del cerebro, el perfilado de células inmunitarias y estudios de detección de biomarcadores. También se presentarán investigaciones colaborativas con instituciones destacadas.
Bio-Techne (NASDAQ: TECH)는 2024년 11월 6일부터 10일 사이 텍사스 주 휴스턴에서 열리는 암 면역요법 학회(SITC) 제39회 연례 회의에 포트폴리오를 선보일 예정입니다. 회사의 공간 생물학 브랜드인 Advanced Cell Diagnostics (ACD)와 Lunaphore는 각각 부스 #613과 #701에서 혁신 기술을 발표합니다.
ACD는 RNAscope™ 기술을 특징으로 하는 공간 다중오믹스 제품을 선보일 것이며, Lunaphore는 자동화된 COMET™ 제품군과 HORIZON™ 이미지 분석 소프트웨어를 시연할 것입니다. 이 회사는 뇌의 다중 오믹스 매핑, 면역 세포 프로파일링 및 바이오마커 탐지 연구를 포함한 연구 응용 프로그램을 강조하는 여러 포스터를 발표할 것입니다. 저명한 기관과의 공동 연구 발표도 포함될 예정입니다.
Bio-Techne (NASDAQ: TECH) présentera son portefeuille lors de la 39ème Réunion Annuelle de la Société pour l'Immunothérapie du Cancer (SITC) qui se déroulera du 6 au 10 novembre 2024 à Houston, Texas. Les marques de biologie spatiale de l'entreprise, Advanced Cell Diagnostics (ACD) et Lunaphore, présenteront leurs innovations aux stands #613 et #701 respectivement.
ACD mettra en avant des produits de multiomique spatiale avec la technologie RNAscope™, tandis que Lunaphore démontrera sa suite automatisée COMET™ et le logiciel d'analyse d'image HORIZON™. L'entreprise présentera plusieurs affiches mettant en lumière les applications de recherche, y compris le mapping multiomique du cerveau, le profilage des cellules immunitaires et les études de détection de biomarqueurs. Des présentations de recherche collaborative avec des institutions de premier plan seront également mises en avant.
Bio-Techne (NASDAQ: TECH) wird sein Portfolio auf dem 39. Jahrestreffen der Society for Immunotherapy of Cancer (SITC) vom 6. bis 10. November 2024 in Houston, Texas, präsentieren. Die räumlichen Biologie-Marken des Unternehmens, Advanced Cell Diagnostics (ACD) und Lunaphore, werden ihre Innovationen an den Ständen #613 und #701 vorstellen.
ACD wird Produkte der räumlichen Multiomik mit RNAscope™-Technologie präsentieren, während Lunaphore seine automatisierte COMET™-Produktreihe und die HORIZON™-Bildanalyse-Software demonstrieren wird. Das Unternehmen wird mehrere Poster zu Forschungsanwendungen vorstellen, darunter Multiomik-Kartierungen des Gehirns, Immunzellprofiling und Studien zur Biomarker-Detektion. Auch werden gemeinschaftliche Forschungspräsentationen mit herausragenden Instituten gezeigt.
- None.
- None.
Bio-Techne's spatial biology brands, Advanced Cell Diagnostics (ACD) and Lunaphore, are revolutionizing spatial biology research with their pioneering innovations that are advancing the development of tailored immunotherapies to improve patient outcomes.
At booth #613, ACD will present its wide range of spatial multiomics products. These products leverage the precise RNAscope™ technology and an advanced protease-free workflow for same-section RNA and protein detection assays. In combination, these capabilities empower drug discovery research, accelerate cell and gene therapy workflows, enable the characterization of key soluble factors and the immune landscape, and support the development of improved diagnostic tools for an accelerated path from translational research to clinical applications.
At booth #701, Lunaphore will showcase its fully-automated, end-to-end COMET™ suite, designed to provide innovative solutions in spatial biology for the translational research community. The complete portfolio will be showcased through product demonstrations. Furthermore, attendees can test the HORIZON™ image analysis software, tailored for COMET hyperplex images, offering new features for intuitive multiomics data and neighborhood analysis.
"Bio-Techne's spatial biology solutions lead the way in developing groundbreaking innovations, shaping the future of scientific discovery," said Dr. Matt McManus, President of Bio-Techne's Diagnostics & Spatial Biology Segment. "Our mission is to empower scientists with cutting-edge technologies to accelerate research and develop the next-generation therapies. We are excited to feature our spatial portfolio at this prestigious conference."
Several scientists from the company and its partners will present posters at the conference highlighting how the industry-leading capabilities of Bio-Techne's solutions enable key research and clinical applications.
Bio-Techne poster presentations:
Multiomic mapping of the brain: same-section, fully-automated spatial RNA and protein detection on mouse frozen tissues
Friday, November 8 at 12:15 - 13:45 & 17:30 - 19:00
Presenter: Alice Comberlato, Ph.D., Lunaphore, a Bio-Techne Brand
Poster number: #81
Novel fully-automated multiomics assay for profiling immune cell landscape and activation states
Friday, November 8 at 12:15 - 13:45 & 17:30 - 19:00
Presenter: Anushka Dikshit, Ph.D, Advanced Cell Diagnostics, a Bio-Techne Brand
Poster number: #85
Qualification of immune checkpoint biomarker antibodies in glioblastoma with multiplex immunofluorescence
Friday, November 8 at 12:15 - 13:45 & 17:30 - 19:00
Presenter: Ruha Adelkar, Bio-Techne
Poster number: #69
High throughput spatial mulitomic assay for assessing immune cell phenotype and function in the tumor microenvironment
Saturday, November 9 at 12:15- 13:45 & 19:00 - 20:30
Presenter: Anushka Dikshit, Ph.D., Advanced Cell Diagnostics, a Bio-Techne Brand
Poster number: #86
Fully automated, novel protease-free workflow for co-detection of protein-protein interaction, individual proteins and mRNA using RNAscope Multiomic LS assay
Saturday, November 9 at 12:15 -13:45 & 19:10 - 20:30
Presenters: Ge-Ah Kim, Advanced Cell Diagnostics, a Bio-Techne Brand
Poster number: #106
A new automated RNAscopeTM assay for the fluorescent co-detection of multiple RNA and protein biomarkers on Roche DISCOVERY ULTRA™
Saturday, November 9 at 12:15- 13:45 & 19:10 - 20:30
Presenters: Renzo Adilardi, Advanced Cell Diagnostics, a Bio-Techne Brand
Poster number: #206
Poster presentations, in collaboration
Application of a novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution for spatial biomarker identification on immunotherapy-treated melanoma patients [research conducted in collaboration with Prof. Paolo Ascierto, National Tumor Institute Fondazione G. Pascale and Nucleai]
Friday, November 8 at 12:15 - 13:45 & 17:30 - 19:00
Presenter: Ettai Markovits, Ph.D., Nucleai
Poster number: #117
Enhanced analysis of tumor microenvironment and immune regulation via an automated adjustable signal amplification technique for multiplex immunofluorescence [research conducted in collaboration with Prof. Janis Taube, Johns Hopkins University School of Medicine]
Saturday, November 9 at13:45 & 19:10 - 20:30
Presenter: François Rivest, Ph.D., Lunaphore, a Bio-Techne Brand
Poster number: #124
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-society-for-immunotherapy-of-cancer-sitc-39th-annual-meeting-302296611.html
SOURCE Bio-Techne Corporation
FAQ
What will Bio-Techne (TECH) present at SITC 2024?
Where can visitors find Bio-Techne's (TECH) exhibits at SITC 2024?
How many research posters will Bio-Techne (TECH) present at SITC 2024?
What new technologies is Bio-Techne (TECH) showcasing at SITC 2024?
